APA (7th ed.) Citation

A, S., T, K., I, R., E, D., J, L., S, O., . . . M, F. (2026). Comparative effectiveness of anti-CD20 therapies and S1P receptor modulators in late-onset multiple sclerosis: Real-world evidence from the MSBase registry. Therapeutic advances in neurological disorders, 19, 17562864261430084. https://doi.org/10.1177/17562864261430084

Chicago Style (17th ed.) Citation

A, Surcinelli, et al. "Comparative Effectiveness of Anti-CD20 Therapies and S1P Receptor Modulators in Late-onset Multiple Sclerosis: Real-world Evidence from the MSBase Registry." Therapeutic Advances in Neurological Disorders 19 (2026): 17562864261430084. https://doi.org/10.1177/17562864261430084.

MLA (9th ed.) Citation

A, Surcinelli, et al. "Comparative Effectiveness of Anti-CD20 Therapies and S1P Receptor Modulators in Late-onset Multiple Sclerosis: Real-world Evidence from the MSBase Registry." Therapeutic Advances in Neurological Disorders, vol. 19, 2026, p. 17562864261430084, https://doi.org/10.1177/17562864261430084.